Klyx

Quick links to important sections

Klyx

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Klyx

Property Description
Active ingredient Docusate (Docusate sodium)
Form Rectal Solution / Micro-enema
Pharmacological class Laxative (Stool Softener)
General purpose Relieving difficulty from hard stool
Origin Synthetic (Anionic Surfactant)

What Type of Medicine is Klyx and What is its Composition?

Klyx is a medication classified as a laxative, specifically identified as an emollient stool softener, intended for alleviating difficulties associated with constipation. The preparation's sole active component is Docusate (often administered as Docusate sodium), a compound recognized for its properties as a softening agent.

The active substance, Docusate, is a synthetic chemical entity that functions as an anionic surfactant. This classification means the substance works by reducing surface tension. Klyx is formulated as a single-ingredient product, where the Docusate is dissolved in an aqueous or hydrophilic vehicle for targeted administration. Docusate serves as a softening agent in the lower gastrointestinal tract.


Klyx's Physical Form and General Therapeutic Purpose

Klyx is prepared as a low-volume Rectal Solution, commonly delivered as a micro-enema, which is administered via the rectal route. This delivery method allows for direct, localized action on retained fecal matter.

The general therapeutic purpose of this preparation is to relieve the discomfort associated with passing hard, dry stool. Docusate acts as a wetting agent, promoting the incorporation of water and lipids into the dry fecal mass. This action softens the stool, assisting the body’s natural elimination process and making bowel movements less strained. The micro-enema format is used when localized and prompt softening is desired.

What side effects are possible with Klyx ?

Possible Side Effects and Safety Information: Klyx

This section details the officially documented adverse reactions and safety constraints for docusate sodium rectal solution, based strictly on governmental regulatory labels such as the FDA and the EMA Summary of Product Characteristics (SmPC).


Documented Adverse Reactions

The undesirable effects are grouped by the body system affected (System-Organ Class or SOC):

System-Organ Class Officially Documented Effects
Gastrointestinal Disorders Local irritation, Anal burning, Rectal pain, Diarrhoea, Stomach cramps
Skin Disorders Urticaria (Hives), Rash

Serious and Clinically Significant Safety Notes

Official regulatory documents highlight specific reactions that may indicate a serious underlying condition or an allergic response. These include rectal bleeding and the failure to have a bowel movement after use, both of which require immediate professional attention. Signs of a serious allergic reaction (such as swelling of the face or throat) are also explicitly listed as a safety concern.

Safety Constraints and Restrictions

Klyx should not be used in the presence of abdominal pain, nausea, or vomiting. The product label also strictly prohibits concurrent use with mineral oil. Prolonged or chronic use is contraindicated by regulators as it can lead to severe complications, including the development of an atonic, non-functioning colon and low potassium levels (hypokalaemia).

Population and Duration Notes

The medicine should generally not be used for more than one week. Regulatory labels note that it is unknown whether docusate is excreted in human breast milk, and studies are lacking to definitively rule out minimal systemic absorption during pregnancy.

Overdose and Emergency Response

Overdose: Klyx Enema — When to Seek Help

The official regulatory profile for Klyx Enema overdose is defined by the risk of salt and chemical imbalances (electrolyte imbalance) resulting from administering too much of the product or using it more often than recommended. Using laxatives for prolonged periods or in excess is undesirable.

Documented Overdose Presentations and Consequences:

System Affected Potential Manifestations
Cardiovascular Irregular heartbeat, slow heart beat (bradycardia), symptoms of low blood pressure (dizziness, light-headedness).
Neurological Convulsions.
Gastrointestinal Nausea, vomiting, diarrhoea, irritation.
Systemic Dehydration, chemical imbalances in the blood, severe tiredness.

Required Emergency Actions:

If there is suspicion that too much Klyx Enema has been administered, or if any severe symptoms occur, urgent medical attention is required, even if symptoms are initially mild or absent. Immediately telephone a doctor, a Poisons Information Centre, or proceed to the nearest hospital's Accident and Emergency department for advice and treatment. The use of more than one enema should be strictly supervised by a healthcare professional.

Therapeutic Uses of Klyx

What Klyx treats: main uses and benefits

Klyx is a rectal solution primarily used for the management of constipation and as a bowel cleanser before medical procedures. It belongs to a group of medications known as osmotic laxatives, which work by softening the stool and stimulating bowel movement through the introduction of fluid into the rectum.

Primary Uses

Klyx is typically utilized in the following clinical situations:

  • Chronic and Occasional Constipation: It is used to relieve persistent or acute constipation when oral treatments are insufficient or inappropriate.
  • Fecal Impaction: The solution helps to soften and facilitate the removal of hardened stool that has become lodged in the rectum.
  • Preoperative Preparation: It is used to clear the lower bowel before surgical procedures to ensure the area is free of waste.
  • Diagnostic Procedures: Klyx is administered prior to examinations such as rectoscopy or colonoscopy to provide a clear view of the intestinal lining.

Mechanism of Action and Benefits

The effectiveness of Klyx is derived from its two active components, docusate sodium and sorbitol. These ingredients work together to provide several benefits for bowel management:

  • Stool Softening: Docusate sodium acts as a surfactant, reducing the surface tension of the stool. This allows water and fats to penetrate the fecal mass, making it softer and easier to pass.
  • Osmotic Effect: Sorbitol draws water into the lower intestine via osmosis. This increase in fluid volume distends the rectum and triggers the natural urge to defecate.
  • Rapid Action: Because the solution is administered locally, it generally produces a bowel movement within a short timeframe, typically between 5 and 20 minutes.
  • Localized Treatment: By acting directly in the rectum and lower colon, the treatment avoids the systemic absorption and digestive transit time associated with oral laxatives.

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Klyx?

The eligibility for Klyx enema is strictly defined by regulatory documents, establishing who may use the medicine and specific populations that are formally contraindicated.

Eligibility Domain Official Status Practical Implication
Age Allowed (Adults & children 4 years) Must not use if under 4 years of age.
Hypersensitivity Contraindicated Must not use with known allergy to docusate sodium, sorbitol, or any component.
Acute Abdominal Conditions Contraindicated Must not use if experiencing intestinal bleeding, active inflammatory bowel disease, or abdominal pain of unknown origin.
Bowel Patency Contraindicated Must not use if any form of bowel obstruction is present.
Duration of Use Restricted Use is limited to a short-term basis; regular or prolonged use (more than one week) is not recommended.

Regulatory documentation confirms the medicine is suitable for adults and children starting at 4 years of age. Use is explicitly prohibited for specific conditions to prevent potential adverse effects; these include conditions that compromise the integrity or function of the bowel, as well as hypersensitivity reactions. The medicine is not intended for chronic use.

What should I know about interactions with other medicines?

Interactions with other Medicines and Products

This section summarizes the officially documented interactions for Docusate (the active ingredient in Klyx), as specified in regulatory prescribing information from governmental health authorities.


Formally Documented Contraindicated Combinations

The most significant and explicitly restricted interaction is with mineral oil (liquid paraffin). Co-administration of Docusate with mineral oil is formally classified as a contraindicated combination in official regulatory documents. This restriction is due to Docusate's action as a surfactant, which enhances the absorption of mineral oil from the digestive tract, increasing the risk of adverse systemic effects associated with the absorbed oil.


Other Pharmacodynamic Interactions

Official regulatory information notes a potential for pharmacodynamic reinforcement when Docusate is used concurrently with other laxative agents. This caution is based on the possibility of additive effects on the bowel, which could increase the likelihood of gastrointestinal symptoms.


Status of Metabolic and Timing-Based Interactions

Regulatory documents do not explicitly state that Docusate is involved in interactions with Cytochrome P450 (CYP) enzymes or drug transporters. Furthermore, official prescribing information does not contain mandatory timing-separation rules (e.g., administering doses a set number of hours apart) or specific interaction warnings related to food, alcohol, or herbal products.

Mechanism of Action

Local Modulation of Interfacial Surface Tension

The mechanism of action for Docusate is entirely physical and non-systemic, exerted locally within the distal colon and rectum. Docusate functions as an anionic surfactant, interacting with the aqueous-lipid interface inside the fecal mass. This action results in a rapid reduction of the interfacial surface tension, which is the physical barrier resisting the mixing of fluids and solid matter. The physiological cascade begins with the enhanced promotion of wetting and emulsification, facilitating the penetration and even incorporation of water and endogenous lipids throughout the solid fecal mass.

Fecal Hydration and Consistency Alteration

This fluid incorporation directly modulates the rheological properties (consistency) of the stool, increasing its pliability and hydration. The mechanism acts exclusively on the physical state of the feces, altering its internal mechanical properties. This alteration minimizes the mechanical resistance of the fecal mass, supporting its movement and evacuation. This physical consequence occurs without concurrent stimulation of muscular contractions (peristalsis), distinguishing its mechanism from motility-regulating agents. The effect is strictly dependent on direct contact with the contents of the intestinal lumen.

Dosage and Administration Information

How Klyx is Used: Dosing and Administration

This section details the high-level usage principles for Klyx (docusate sodium micro-enema).


Administration Route and Dosing

Klyx is a low-volume Rectal Solution and is approved for the rectal route only, ensuring localized action.

Population Standard Regimen Maximum Recommended Dose
Adults and Children 12 years and older One unit (283 mg Docusate Sodium in 5 mL) administered as a single dose. Not to exceed three units (enemas) in 24 hours.
Children under 12 years Consultation with a doctor is required prior to use. Use and dose must be determined by a doctor.

Frequency, Duration, and Procedure

Klyx is intended for intermittent, short-term use only, administered on an as-needed basis. It is recommended not to use this product for a period longer than 7 consecutive days unless directed by a healthcare professional.

Key Administration Steps:

  1. The applicator tip must be removed and lubricated prior to insertion.
  2. The unit is inserted slowly into the rectum, typically up to the shoulder of the tip.
  3. The entire contents of the tube must be squeezed to empty the medication.
  4. The tube should be kept squeezed while it is being removed from the rectum to ensure proper retention.

These instructions define the standardized approach for the correct use of this medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Klyx


Evidence for Use in Acute, Difficult Constipation

Research exploring this medicine for short-term difficulties associated with hard, retained stool has involved Randomized Controlled Trials (RCTs) and comparative studies. These studies primarily focused on patients experiencing acute constipation or fecal retention. Researchers monitored outcomes related to physical discomfort, such as the time to first bowel movement and objective changes in stool consistency.

Findings describe patterns observed in the studies where the preparation was evaluated for rapid, localized action. Trials reported measurements of time to evacuation that were often compared to those achieved by certain other agents used for acute constipation. However, systematic research on the active ingredient, Docusate, has focused heavily on its oral form, where the evidence quality for the oral form is often summarized as limited or mixed. The available evidence for the rectal solution often involved comparative trials using other active agents, limiting direct comparison to inactive placebos.

What remains uncertain is the role of this product in managing long-term or chronic constipation, as follow-up durations were limited in most relevant studies. The research provides context on acute episodes but does not determine whether an individual will respond similarly during prolonged use.


Evidence for Lower Bowel Preparation

The rectal solution was evaluated in research contexts involving specific clinical necessity, particularly its use for achieving lower bowel clearance before diagnostic examinations. This research primarily involved Randomized Comparative Trials where this preparation was studied against other methods used for pre-procedural bowel cleansing.

Studies monitored outcomes reflecting daily functioning, specifically the quality and completeness of bowel cleansing as assessed by a clinician, and the time taken to achieve satisfactory clearance. The findings describe patterns observed in the studies where the preparation was studied as an agent for achieving distal bowel cleansing for certain procedures.

Reported measurements of cleansing quality were observed in trials that also included other localized preparation agents. These studies focused on episodes where symptoms become more noticeable, such as before a scheduled procedure. Comparative evidence is lacking for its use as a full-scale alternative to high-volume oral preparation regimens needed for full colon examinations.


Long-Term Studies and Follow-Up

Research exploring short-term symptom changes is common for this preparation, but long-term effects are not fully established. The follow-up durations were limited in most of the existing trials, with monitoring often restricted to the acute episode (one day to 10 days).

There is limited information for long-term outcomes or the durability of symptom response. Studies focusing on the potential consequences of prolonged or maintenance use are currently scarce. Data are still emerging for extended use scenarios.

Key Studies & References

  1. Management of Constipation in Adults (Clinical Guideline specifying rectal docusate use)
  2. How useful is docusate in patients at risk for constipation: a systematic review of the evidence in the chronically ill (NCBI)

Frequently Asked Questions (FAQ)

Common questions about Klyx (FAQ)


Q: Is Klyx available over the counter, or does it need a prescription?

Docusate micro-enemas are generally classified by some global regulatory authorities as an Over-The-Counter (OTC) medicine. This classification means that in many regions, the product may be supplied to the user without needing a prescription from a doctor.


Q: How quickly should someone expect Klyx to start working?

Official product information for docusate enemas indicates that the preparation is designed for rapid, localized action. The timeframe for a bowel movement to occur is typically short, often described in regulatory documents as being within 5 to 20 minutes after administration.


Q: Does Klyx have a strong or noticeable odor?

Regulatory safety documents that detail the composition of docusate sodium and glycerin formulations often list the odor of the product as odorless. This indicates that the preparation should not be expected to have a strong or noticeable smell.


Q: Can Klyx be used for short-term and long-term purposes?

According to official documents, the product is authorized and described for short-term use only to relieve acute difficulties. Regulatory documents strictly warn against prolonged or chronic use, as this includes the potential for the bowel to develop a reliance on the product.


Q: Do any official documents describe Klyx as habit-forming?

Official consumer information states that using laxative products, including this one, for longer than the recommended short duration is undesirable. This prolonged use may lead to dependence, meaning the body may start to rely on the product for normal function.


Q: Can Klyx be used by people who have other stomach or digestive issues?

Regulatory documents advise against using the product when certain severe symptoms of other digestive issues are present. The presence of abdominal pain, nausea, or vomiting of unknown origin is listed as a condition where use is advised against.


Q: What should be done if someone accidentally uses Klyx more than once in a short period?

Official documents define a maximum recommended dose per 24 hours. In scenarios of overdose, official guidance advises seeking immediate advice by contacting a Poisons Information Centre, a doctor, or a hospital's emergency department.


Q: Does Klyx affect blood pressure or heart rhythm?

Official patient information for the active ingredient often lists certain pre-existing conditions as medical circumstances where the medicine is not recommended. These conditions include congestive heart failure and high blood pressure.


Q: What is the difference between the active ingredient in Klyx and similar treatments?

The active ingredient, docusate, is classified as an emollient stool softener and anionic surfactant. This means it works by hydrating and softening the stool, which is a mechanism that distinguishes it from stimulant laxatives, which work by increasing muscle contractions in the bowel.


Q: What should someone know about the feeling or sensation of using Klyx for the first time?

Official regulatory documents list certain documented local adverse reactions that may be felt during or immediately after use. These commonly reported sensations include local irritation, anal burning, and rectal pain.


Q: Does Klyx contain any common allergens like gluten or soy?

The inactive ingredients are fully listed in official labels. While the specific inactive ingredients generally do not include common allergens such as gluten or soy, they typically contain compounds like Polyethylene Glycol and a vehicle such as Glycerin or Sorbitol.


Q: Is Klyx known to interact with herbal supplements?

Official patient guides advise that there is not enough scientific information to definitively state that complementary medicines, herbal remedies, and nutritional supplements are safe to take with docusate. Regulatory sources generally recommend informing a healthcare provider about all products being taken.


Q: What is the typical timeframe between doses if used regularly, based on official information?

The product is intended for intermittent use on an as-needed basis as a single dose, not for regular daily dosing. If a second dose is needed, regulatory instructions permit using it later on the same day or the next day, provided the stated maximum dose is not exceeded within a 24-hour period.


Q: Why does the packaging for Klyx include a warning about dehydration?

Warnings about the risk of dehydration are included because using the product for too long or administering an overdose may result in excessive purging and diarrhoea. This excessive fluid loss can potentially cause a loss of body fluids and disrupt the chemical balance in the blood.


Q: Is the quantity of the drug consistent across different brands of Klyx?

While the active ingredient is the same, regulatory guides show that rectal doses of docusate enemas commonly fall within a range. Typically, they are described as 200 mg to 283 mg of docusate sodium, but the exact quantity can vary between specific brands and formulations.


Q: Does Klyx affect fertility in men or women?

Official regulatory patient information states that there is no evidence to suggest that the short-term use of docusate has any effect on fertility in either men or women.


Q: Is it possible to develop a tolerance to Klyx over time?

Official consumer information warns against prolonged use, noting that this may result in the bowel becoming dependent on the product over time, which is similar to the bowel developing a dependence on the product.


Q: What happens if Klyx is exposed to high temperatures?

Regulatory guidance requires the product to be stored under controlled conditions, typically below 25 C (77 F), and protected from excessive heat. Exposure to temperatures higher than the recommended storage range may adversely affect the efficacy or reduce the shelf life of the medicine.


Q: Are there different strengths or formulations of Klyx?

Yes, regulatory documents list various forms of the active ingredient, Docusate. These include different salt forms (like sodium, calcium, and potassium) and different strengths, such as the standard 200 mg to 283 mg in the rectal solution format.


Q: Can Klyx be used during pregnancy, according to official information?

The official status is that studies are lacking to definitively rule out minimal systemic absorption of the medicine during pregnancy. It is also unknown whether docusate is excreted in human breast milk, according to regulatory sources.


Q: Can someone use Klyx while also taking a multivitamin?

Official patient guides advise telling a doctor or pharmacist if the user is taking any vitamins or supplements. This is because there is limited official information available regarding their specific interaction with docusate.


Q: Is it possible to be allergic to Klyx?

Yes, official regulatory information lists a known allergy or Hypersensitivity to any component of the medicine as a formal contraindication. Signs of a serious allergic reaction are also explicitly listed as a safety concern requiring immediate medical attention.


Q: Can Klyx be used by someone with diabetes?

Official patient information notes that some liquid forms of the active ingredient may contain large amounts of sugar. The use of the product is generally not restricted for people with diabetes, but official guidance recommends that a health professional be informed of all existing conditions.


Q: What type of medical professional typically prescribes Klyx?

Regulatory documents refer to the medicine being prescribed by a medical practitioner or supplied by a pharmacist. The professional who prescribes or supplies it depends on the product's official classification (prescription or over-the-counter) in a given region.

How should Klyx be stored and disposed of?

Storage and Disposal Conditions for Klyx

The storage and handling of Klyx (Docusate sodium/Sorbitol micro-enema) must strictly follow regulatory guidance to maintain product stability and safety.

Storage Requirements

Klyx must be stored in a cool, dry place where the temperature stays below 25°C (77°F). It is mandatory to protect the product from freezing and direct sunlight, as well as excessive heat and dampness. The medicine should be kept in its original pack until the time of use.

Child Safety and Disposal

For safety, the product must be stored out of the sight and reach of children and pets. Do not use Klyx after the expiry date printed on the label. Any unused, expired, or damaged medicine must be returned to a pharmacist for proper disposal, as instructed by regulatory documents for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Klyx  found in:

A-Z Index: